ILK and breast carcinoma: reported that NETs can bind to cancer cells through CCDC25 receptor and activate the integrin linked kinase (ILK)-β-PARVIN-RAC1-CDC42 cascade in breast cancer cells thus enhancing motility, invasion and proliferation (17).